In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
After finishing at $1.78 in the prior trading day, Precigen Inc (NASDAQ: PGEN) closed at $1.70, down -4.49%. In other words, the price has decreased by -$4.49 from its previous closing price. On the day, 1.86 million shares were traded. PGEN stock price reached its highest trading level at $1.8018 during the session, while it also had its lowest trading level at $1.63.
Ratios:
Our goal is to gain a better understanding of PGEN by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.63 and its Current Ratio is at 1.63. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.09.
On November 18, 2022, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $7.Cantor Fitzgerald initiated its Overweight rating on November 18, 2022, with a $7 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 09 ’24 when Perez Jeffrey Thomas bought 58,823 shares for $0.85 per share. The transaction valued at 50,000 led to the insider holds 743,097 shares of the business.
KIRK RANDAL J bought 23,529,411 shares of PGEN for $19,999,999 on Aug 09 ’24. The Director now owns 64,547,214 shares after completing the transaction at $0.85 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PGEN now has a Market Capitalization of 497877312 and an Enterprise Value of 209969488. For the stock, the TTM Price-to-Sale (P/S) ratio is 125.73 while its Price-to-Book (P/B) ratio in mrq is 8.99. Its current Enterprise Value per Revenue stands at 47.84 whereas that against EBITDA is -2.37.
Stock Price History:
The Beta on a monthly basis for PGEN is 1.61, which has changed by 0.27142859 over the last 52 weeks, in comparison to a change of 0.21313763 over the same period for the S&P500. Over the past 52 weeks, PGEN has reached a high of $1.93, while it has fallen to a 52-week low of $0.65. The 50-Day Moving Average of the stock is 58.72%, while the 200-Day Moving Average is calculated to be 43.44%.
Shares Statistics:
The stock has traded on average 1.70M shares per day over the past 3-months and 2000590 shares per day over the last 10 days, according to various share statistics. A total of 292.87M shares are outstanding, with a floating share count of 162.72M. Insiders hold about 44.44% of the company’s shares, while institutions hold 26.56% stake in the company. Shares short for PGEN as of 1730332800 were 15321505 with a Short Ratio of 11.10, compared to 1727654400 on 15695513. Therefore, it implies a Short% of Shares Outstanding of 15321505 and a Short% of Float of 7.99.
